Group photo2.png

CEBINA is led by a team of highly experienced academic and medical research scientists and entrepreneurs with decades-long experience in product development and biotech innovation

Management Team

Eszter Nagy, MD, PhD

CEO, CSO Founder

Over 20 years of biotech experience and serial entrepreneurship, successfully raising >€40M VC financing and €16M non-dilutive funding

Co-founder, CEO Calyxha Biotechnologies GmbH; Co-founder, president Eveliqure Biotechnologies GmbH; CEO, CSO Algonist Biotechnologies GmbH

Previously:  Co-founder & CSO Arsanis, Inc (IPO, NASDAQ 2017, now X4 Pharma); SVP Research, Intercell AG (now Valneva SAS)

Mag. Wolfgang Friedl


CEBINA operations, facility, investor relations and legal

Attorney at Law, founder and senior partner of Vienna Legal Group

25 years experience in corporate law, national / international M&A, and financing with a strong focus on biotech

Sophie Zettl, PhD

VP Business Development

Business development, intellectual property, PR and communications

15 years licensing / BD / IP experience in biotech, Pharma and University Technology Transfer Offices​; CBO, COO Algonist Biotechnologies GmbH


Previously: Arsanis Inc, MedImmune / AstraZeneca, University College London, King’s College London

Gábor Nagy MD, PhD

Head of Research & Technology Evaluation

12 years biotech R&D experience


Previously: Arsanis Inc, Eveliqure Biotechnologies GmbH (co-founder), Intercell AG (now Valneva SAS)

Valéria Szijártó, MD, PhD

Head of Preclinical & Translational Research

8 years biotech R&D experience


Previously: Arsanis Inc, Eveliqure Biotechnologies GmbH 

Advisors and Investments

Patrick Aisher

Strategic investor / Investment advisor

Chairman of Kinled Holding investing in life science, digital & financial technologies


Direct investments in > 50 businesses, 24 exiting via IPO, trade sale or licensing


Partner in four life science funds with $300M AuM

Fabio Blom

Investment Committee Member​